{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:15:45Z","timestamp":1792822545080,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12028-021-01331-z","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T19:36:51Z","timestamp":1630697811000},"page":"669-679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Intravenous Milrinone for Cerebral Vasospasm in Subarachnoid Hemorrhage: The MILRISPASM Controlled Before\u2013After Study"],"prefix":"10.1007","volume":"35","author":[{"given":"Karim","family":"Lakhal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Hivert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Louis","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Fresco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Robert-Edan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Andr\u00e9","family":"Rodie-Talbere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Rozec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Cadiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,3]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13054-016-1193-9","volume":"20","author":"AL de Oliveira Manoel","year":"2016","unstructured":"de Oliveira Manoel AL, Goffi A, Marotta TR, Schweizer TA, Abrahamson S, Macdonald RL. The critical care management of poor-grade subarachnoid haemorrhage. Crit Care Lond Engl. 2016;20:21.","journal-title":"Crit Care Lond Engl"},{"issue":"2","key":"1331_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","volume":"15","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Bleck TP, Claude-Hemphill J, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society\u2019s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211\u201340.","journal-title":"Neurocrit Care"},{"issue":"6","key":"1331_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/american Stroke Association. Stroke. 2012;43(6):1711\u201337.","journal-title":"Stroke"},{"issue":"6","key":"1331_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3171\/jns.1991.74.6.0985","volume":"74","author":"ME Linskey","year":"1991","unstructured":"Linskey ME, Horton JA, Rao GR, Yonas H. Fatal rupture of the intracranial carotid artery during transluminal angioplasty for vasospasm induced by subarachnoid hemorrhage Case report. J Neurosurg. 1991;74(6):985\u201390.","journal-title":"J Neurosurg"},{"issue":"9","key":"1331_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00234-007-0252-y","volume":"49","author":"AA Dawkins","year":"2007","unstructured":"Dawkins AA, Evans AL, Wattam J, et al. Complications of cerebral angiography: a prospective analysis of 2,924 consecutive procedures. Neuroradiology. 2007;49(9):753\u20139.","journal-title":"Neuroradiology"},{"issue":"6","key":"1331_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1177\/1538574406294075","volume":"40","author":"C Derham","year":"2006","unstructured":"Derham C, Davies JF, Shahbazi R, Homer-Vanniasinkam S. Iatrogenic limb ischemia caused by angiography closure devices. Vasc Endovasc Surg. 2006;40(6):492\u20134.","journal-title":"Vasc Endovasc Surg"},{"issue":"3","key":"1331_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1227\/NEU.0b013e31827d0ff7","volume":"72","author":"PS Kelkar","year":"2013","unstructured":"Kelkar PS, Fleming JB, Walters BC, Harrigan MR. Infection risk in neurointervention and cerebral angiography. Neurosurgery. 2013;72(3):327\u201331.","journal-title":"Neurosurgery"},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.wneu.2020.02.092","volume":"137","author":"H Sakata","year":"2020","unstructured":"Sakata H, Endo H, Fujimura M, Niizuma K, Tominaga T. Symptomatic cerebral hyperperfusion after cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage. World Neurosurg. 2020;137:379\u201383.","journal-title":"World Neurosurg"},{"issue":"11","key":"1331_CR9","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1097\/01.CCM.0000185644.54646.65","volume":"33","author":"N Bercault","year":"2005","unstructured":"Bercault N, Wolf M, Runge I, Fleury J-C, Boulain T. Intrahospital transport of critically ill ventilated patients: a risk factor for ventilator-associated pneumonia\u2013a matched cohort study. Crit Care Med. 2005;33(11):2471\u20138.","journal-title":"Crit Care Med"},{"issue":"1","key":"1331_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12028-018-0604-y","volume":"30","author":"J K\u00fcchler","year":"2019","unstructured":"K\u00fcchler J, Tronnier F, Smith E, Gliemroth J, Tronnier VM, Ditz C. The impact of intrahospital transports on brain tissue metabolism in patients with acute brain injury. Neurocrit Care. 2019;30(1):216\u201323.","journal-title":"Neurocrit Care"},{"issue":"1","key":"1331_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12028-016-0291-5","volume":"26","author":"M Martin","year":"2017","unstructured":"Martin M, Cook F, Lobo D, et al. Secondary insults and adverse events during intrahospital transport of severe traumatic brain-injured patients. Neurocrit Care. 2017;26(1):87\u201395.","journal-title":"Neurocrit Care"},{"issue":"2","key":"1331_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s12028-008-9048-0","volume":"11","author":"CM Romero","year":"2009","unstructured":"Romero CM, Morales D, Reccius A, et al. Milrinone as a rescue therapy for symptomatic refractory cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):165\u201371.","journal-title":"Neurocrit Care"},{"issue":"3","key":"1331_CR13","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1213\/ANE.0b013e3181cc9ed8","volume":"110","author":"U Schmidt","year":"2010","unstructured":"Schmidt U, Bittner E, Pivi S, Marota JJ. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and\/or milrinone. Anesth Analg. 2010;110(3):895\u2013902.","journal-title":"Anesth Analg"},{"issue":"2","key":"1331_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1017\/cjn.2016.316","volume":"44","author":"M Lannes","year":"2016","unstructured":"Lannes M, Zeiler F, Guichon C, Teitelbaum J. The use of milrinone in patients with delayed cerebral ischemia following subarachnoid hemorrhage: a systematic review. Can J Neurol Sci. 2016;44(2):152\u201360.","journal-title":"Can J Neurol Sci"},{"issue":"3","key":"1331_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/STROKEAHA.107.492447","volume":"39","author":"AT Fraticelli","year":"2008","unstructured":"Fraticelli AT, Cholley BP, Losser M-R, Saint Maurice J-P, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39(3):893\u20138.","journal-title":"Stroke"},{"issue":"3","key":"1331_CR16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s12028-012-9701-5","volume":"16","author":"M Lannes","year":"2012","unstructured":"Lannes M, Teitelbaum J, del Pilar CM, Cardoso M, Angle M. Milrinone and homeostasis to treat cerebral vasospasm associated with subarachnoid hemorrhage: the Montreal Neurological Hospital protocol. Neurocrit Care. 2012;16(3):354\u201362.","journal-title":"Neurocrit Care"},{"issue":"3","key":"1331_CR17","first-page":"168","volume":"32","author":"LJ Velly","year":"2015","unstructured":"Velly LJ, Bilotta F, Fabregas N, Soehle M, Bruder NJ, Nathanson MH. Anaesthetic and ICU management of aneurysmal subarachnoid haemorrhage: a survey of European practice. Eur J Anaesthesiol. 2015;32(3):168\u201376.","journal-title":"Eur J Anaesthesiol"},{"key":"1331_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jns.2018.12.027","volume":"397","author":"K Lakhal","year":"2019","unstructured":"Lakhal K, Rodie-Talbere P-A, Alexandre P-L, Testard N, Rozec B, Daumas-Duport B. Continuous intravenous milrinone for severe reversible cerebral vasoconstriction syndrome (a case report). J Neurol Sci. 2019;397:55\u20137.","journal-title":"J Neurol Sci"},{"issue":"6","key":"1331_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1097\/CCM.0000000000003716","volume":"47","author":"KA Morbitzer","year":"2019","unstructured":"Morbitzer KA, Jordan JD, Dehne KA, Durr EA, Olm-Shipman CM, Rhoney DH. Enhanced renal clearance in patients with hemorrhagic stroke. Crit Care Med. 2019;47(6):800\u20138.","journal-title":"Crit Care Med"},{"key":"1331_CR20","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/j.wneu.2020.10.008","volume":"145","author":"K Rumalla","year":"2021","unstructured":"Rumalla K, Lin M, Ding L, et al. Risk factors for cerebral vasospasm in aneurysmal subarachnoid hemorrhage: a population-based study of 8346 patients. World Neurosurg. 2021;145:e233\u201341.","journal-title":"World Neurosurg"},{"issue":"16","key":"1331_CR21","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1161\/CIRCULATIONAHA.108.790162","volume":"118","author":"GA Fleming","year":"2008","unstructured":"Fleming GA, Murray KT, Yu C, et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery. Circulation. 2008;118(16):1619\u201325.","journal-title":"Circulation"},{"issue":"9","key":"1331_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1056\/NEJMoa0907118","volume":"362","author":"D De Backer","year":"2010","unstructured":"De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779\u201389.","journal-title":"N Engl J Med"},{"key":"1331_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/neurosurgery\/16.CN_suppl_1.436","volume":"16","author":"TW Langfitt","year":"1969","unstructured":"Langfitt TW. Increased intracranial pressure. Clin Neurosurg. 1969;16:436\u201371.","journal-title":"Clin Neurosurg"},{"issue":"12","key":"1331_CR24","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1136\/jnnp.54.12.1044","volume":"54","author":"B Farrell","year":"1991","unstructured":"Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54(12):1044\u201354.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1331_CR25","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1097\/CCM.0000000000003459","volume":"47","author":"K Lakhal","year":"2019","unstructured":"Lakhal K, Robert-Edan V, Fresco M, et al. Transcranial Doppler in the diagnosis of cerebral vasospasm: a call for a dynamic approach. Crit Care Med. 2019;47(2):e164\u20135.","journal-title":"Crit Care Med"},{"key":"1331_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/2020.1.JNS193107","volume":"1","author":"YB Abulhasan","year":"2020","unstructured":"Abulhasan YB, Ortiz Jimenez J, Teitelbaum J, Simoneau G, Angle MR. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia. J Neurosurg. 2020;1:1\u201312.","journal-title":"J Neurosurg"},{"issue":"23","key":"1331_CR27","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function\u2013measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473\u201383.","journal-title":"N Engl J Med"},{"issue":"3","key":"1331_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/ANA.0000000000000527","volume":"31","author":"T Crespy","year":"2019","unstructured":"Crespy T, Heintzelmann M, Chiron C, et al. Which protocol for milrinone to treat cerebral vasospasm associated with subarachnoid hemorrhage? J Neurosurg Anesthesiol. 2019;31(3):323\u20139.","journal-title":"J Neurosurg Anesthesiol"},{"issue":"1","key":"1331_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.egja.2013.07.006","volume":"30","author":"MA Ghanem","year":"2014","unstructured":"Ghanem MA, Shabana AM. Effects of Milrinone continuous intravenous infusion on global cerebral oxygenation and cerebral vasospasm after cerebral aneurysm surgical clipping. Egypt J Anaesth. 2014;30(1):73\u201382.","journal-title":"Egypt J Anaesth"},{"issue":"4","key":"1331_CR30","first-page":"723","volume":"48","author":"Y Arakawa","year":"2001","unstructured":"Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48(4):723\u20138.","journal-title":"Neurosurgery"},{"issue":"4","key":"1331_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.5935\/0103-507X.20200097","volume":"32","author":"AG Santos-Teles","year":"2020","unstructured":"Santos-Teles AG, Ramalho C, Ramos JGR, et al. Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review. Rev Bras Ter Intensiva. 2020;32(4):592\u2013602.","journal-title":"Rev Bras Ter Intensiva"},{"issue":"1","key":"1331_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/STROKEAHA.117.017956","volume":"49","author":"CS Gathier","year":"2018","unstructured":"Gathier CS, van den Bergh WM, van der Jagt M, et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a randomized clinical trial. Stroke. 2018;49(1):76\u201383.","journal-title":"Stroke"},{"issue":"3","key":"1331_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.accpm.2018.10.002","volume":"38","author":"R Cinotti","year":"2019","unstructured":"Cinotti R, Putegnat J-B, Lakhal K, et al. Evolution of neurological recovery during the first year after subarachnoid haemorrhage in a French university centre. Anaesth Crit Care Pain Med. 2019;38(3):251\u20137.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"1331_CR34","unstructured":"University Hospital, Angers. Milrinone infusion for VAsospam treatment in subarachnoid hemoRrhage. clinicaltrials.gov; 2020. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04362527."},{"issue":"6","key":"1331_CR35","first-page":"985","volume":"68","author":"CG Drake","year":"1988","unstructured":"Drake CG. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68(6):985\u20136.","journal-title":"J Neurosurg"},{"issue":"9","key":"1331_CR36","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1161\/hs0901.095677","volume":"32","author":"J Claassen","year":"2001","unstructured":"Claassen J, Bernardini GL, Kreiter K, et al. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited. Stroke. 2001;32(9):2012\u201320.","journal-title":"Stroke"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01331-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-021-01331-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-021-01331-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T10:53:26Z","timestamp":1673175206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-021-01331-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s12028-021-01331-z","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,3]]},"assertion":[{"value":"24 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KL has no conflict of interest in connection with the work submitted. In addition, KL received, during the past 3\u00a0years, congress registration fees from Sanofi Aventis (once in 2018), travel fees from Merck Sharp & Dohme (MSD) France (once, in 2017), Gilead Sciences (once, in 2017), pfizer (twice, in 2019 and 2020) and Correvio (twice, in 2020). BR has no conflict of interest in connection with the work submitted. In addition, BR received, during the past 5\u00a0years, lecture fees from Fisher&Paykel, Baxter, LFB, Aspen, research grants from Baxter and consulting fees from LFB, Astra Zeneca. None of the other authors has any financial or nonfinancial competing interest in connection with this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013). At our institution, intravenous milrinone has been incorporated into routine care several years ago, a dedicated institutional written procedure guiding its use for moderate\/severe vasospasms. In patients who were included prospectively (IV milrinone group), consent to use the data for this observational study was obtained from all participants (patients or their next of kin then the patients themselves if they regained capacity) after oral and written reminding of their rights. For patients included retrospectively (historical control cohort), informed consent was waived. Anonymity was respected. This research has been approved by an independent ethical committee (Comit\u00e9 de Protection des Personnes Sud-Ouest & Outre-Mer III, March 2018, N\u00b0 2017-A03347-46, amended in march 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}},{"value":"Ref. NCT 03517670.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trials Registration"}}]}}